Upregulation of Complement Regulators MCP (CD46), DAF (CD55) and Protectin (CD59) in Arthritic Joint Disease

References

• Cherian P V, Schumacher HR. Immunoelectronmicroscopic characterization of intracellular inclusions in synovial fluid cells of patients with rheumatoid arthritis. Ultrastruct Pathol 1983; 5: 15–27
   PubMed Web of Science ®Google Scholar
• Cooke T D, Hurd E R, Jasin H E, Bienenstock J, Ziff M. Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum 1975; 18: 541–51
   PubMed Web of Science ®Google Scholar
• Menninger H, Lambusch M, Mohr W, Wessinghage D. Immunkomplexe: Mediatoren fur die Bildung von enuündlichem Granulationsgewebe?. Z Rheumatol 1983; 42: 7–15
   PubMed Web of Science ®Google Scholar
• Liszewski M K, Post T W, Atkinson JP. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Ann Rev Immunol 1991; 9: 431–55
   PubMed Web of Science ®Google Scholar
• Lublin D M, Atkinson JP. Decay-accelerating factor: biochemistry, molecular biology and function. Ann Rev Immunol 1989; 7: 35–58
   PubMed Web of Science ®Google Scholar
• Oglesby T J, Allen C J, Liszewski M K, White D JG, Atkinson JP. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 1992; 175: 1547–51
   PubMedGoogle Scholar
• Johnstone R W, Loveland B E, McKenzie I FC. Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 1993; 79: 341–7
   PubMed Web of Science ®Google Scholar
• Medof M E, Walter E I, Rutgers J L, Knowles D M, Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 1987; 165: 848–64
   PubMed Web of Science ®Google Scholar
• Meri S, Waldmann H, Lachmann PJ. Distribution of protectin (CD59) a complement attack inhibitor in normal human tissues. Lab Invest 1991; 65: 532–7
   PubMed Web of Science ®Google Scholar
• Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Davies M E, Horner A, Franz B, Schuberth HJ. Detection of cytokine-activated chondrocytes in arthritic joints from pigs infected with Erysipelothrix rhusiopathiae. Ann Rheum Dis 1992; 51: 978–82
   PubMed Web of Science ®Google Scholar
• Dingle J T, Davies M E, Mativi B Y, Middleton HF. Immunohistological identification of interleukin-1 activated chondrocytes. Ann Rheum Dis 1990; 49: 889–92
   PubMed Web of Science ®Google Scholar
• Sparrow R L, McKenzie I FC. HuLy-m5: a unique antigen physically associated with HLA molecules. Hum Immunol 1983; 7: 1–15
   PubMed Web of Science ®Google Scholar
• Coyne K E, Hall S E, Thompson E S, Arce M A, Kinoshita T, Fujita T, et al. Mapping of epitopes, glycosylation sites and complement regulatory domains in human decay accelerating factor. J Immunol 1992; 149: 2906–13
   PubMed Web of Science ®Google Scholar
• Stefanova I, Hilgert I, Kristofoca H, Brown R, Low M G, Horejsi V. Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol. Mol Immunol 1989; 26: 153–61
   PubMed Web of Science ®Google Scholar
• Stemme S, Patarroyo M, Hanson GK. Adhesion of activated T lymphocytes to vascular smooth muscle cells and dermal fibroblasts is mediated by β1-and β2-integrins. Scand J Immunol 1992; 36: 233–42
   PubMed Web of Science ®Google Scholar
• Davies M E, Dingle J T, Pigott R, Power C, Sharma H. Expression of intercellular adhesion molecule 1 (ICAM-1) on human articular cartilage chondrocytes. Connect Tissue Res 1991; 26: 207–16
   PubMed Web of Science ®Google Scholar
• Purcell D FJ, McKenzie I FC, Lublin D M, Johnson P M, Atkinson J P, Oglesby T J, et al. The human cell-surface glycoproteins HuLy-m5 membrane cofactor protein (MCP) of the complement system and trophoblast-Ieucocyte common (TLX) antigen are CD46. Immunology 1990; 70: 155–61
   PubMed Web of Science ®Google Scholar
• Eraser S M, Hopkins R, Hunter J A, Neumann V, Capell H A, Bird HA. Sulphasalazine in the management of psoriatic arthritis. Br J Rheumatol 1993; 32: 923–5
   PubMedGoogle Scholar
• Firestein G S, Alvaro-Garcia J M, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144: 3347–53
   PubMed Web of Science ®Google Scholar
• Brennan F M, Field M, Chu C Q, Feldmann M, Maini RN. Cytokine expression in rheumatoid arthritis. Br J Rheumatol 1991; 30: 76–80, Suppl 1
   PubMedGoogle Scholar
• Hopkins S J, Humphries M, Jayson M IV. Cytokines in synovial fluid. Clin Exp Immunol 1988; 72: 422–7
   PubMed Web of Science ®Google Scholar
• Smith J B, Bocchieri M H, Sherbin-Allen L, Borofsky M, Abruzzo JL. Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay inhibiting factors. Rheumatol Int 1989; 9: 53–8
   PubMed Web of Science ®Google Scholar
• Itoh J, Nose M, Fujita T, Kato M, Ohyama A, Kyogoku M. Expression of decay-accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid arthritis. Clin Exp Immunol 1991; 83: 364–8
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN. Immune complexes. Textbook of Rheumatology3rd Edn., WN Kelly, ED Harris, S Ruddy, CB Sledge. Philadelphia; W.B, Saunders Company 1989; 226–39
   Google Scholar
• Winchester R J, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lowered complement levels. Clin Exp Immunol 1970; 6: 689–706
   PubMed Web of Science ®Google Scholar
• Ruddy S, Austen KF. Activation of the complement system in rheumatoid synovitis. Fed Proc 1973; 32: 134–7
   PubMedGoogle Scholar
• Moore T L, Sheridan P W, Traycoff R B, Zuckner J, Dorner RW. Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods. J Rheumatol 1982; 9: 395–401
   PubMed Web of Science ®Google Scholar
• Miller JJ, III, Osborne C L, Hsu Y-P. Clq binding in serum in juvenile rheumatoid arthritis. J Rheumatol 1980; 7: 665–70
   PubMedGoogle Scholar
• Thomsen B S, Heilmann C, Jacobsen S EH, Pedersen F K, Morling N, Jakobsen B K, et al. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1987; 30: 967–71
   PubMedGoogle Scholar
• Medof E, Kinoshita T, Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 1984; 160: 1558–78
   PubMed Web of Science ®Google Scholar
• McGeer P L, Walker D G, Akuyama H, Kawamata T, Guan A L, Parker C J, Okada N, McGeer EG. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res 1991; 544: 315–9
   PubMed Web of Science ®Google Scholar
• Schnabel J. Alzheimer's disease: arthritis of the brain?. New Scientist 1993; 1878: 22–6
   Google Scholar